Date Filed | Type | Description |
09/28/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
08/23/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
08/15/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/15/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
06/06/2023 |
8-K/A
| Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Financial State... |
05/16/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
05/02/2023 |
RW
| Form RW - Registration Withdrawal Request: |
04/17/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
02/24/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
01/25/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
12/15/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
12/06/2022 |
8-K
| Quarterly results |
12/06/2022 |
8-K
| Quarterly results |
12/02/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
11/18/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
11/14/2022 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
08/11/2022 |
8-K
| Quarterly results |
08/09/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data
Docs:
|
"Mill City Ventures III, Ltd. Announces Pricing of $5.0 Million Public Offering and Concurrent Uplisting to the Nasdaq Capital Market MINNEAPOLIS, August 8, 2022 /PRNewswire/ -- Mill City Ventures III, Ltd. a non-bank lender and specialty finance company, today announced the pricing of its underwritten public offering of 1,250,000 shares of common stock at a public offering price of $4.00 per share, for aggregate gross proceeds of $5,000,000, before underwriting discounts and commissions. In addition, the Company has granted the underwriters a 45-day option to purchase up to 187,500 additional shares of common stock at the offering price, less the underwriting discount. The Company expects to commence trading on the Nasdaq Capital Market tomorrow. In connection with the Nasdaq listing, the..." |
|
08/09/2022 |
CERT
| Form CERT - Certification by an exchange approving securities for listing: |
08/09/2022 |
424B4
| Form 424B4 - Prospectus [Rule 424(b)(4)]: |
08/09/2022 |
8-A12B
| Form 8-A12B - Registration of securities [Section 12(b)]: |
08/09/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
08/08/2022 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
08/04/2022 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
07/28/2022 |
FWP
| Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses: |
07/28/2022 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
06/08/2022 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
05/13/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
03/14/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
02/11/2022 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
11/12/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
10/14/2021 |
10-Q/A
| Quarterly Report for the period ended June 30, 2021 [amend] |
08/13/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
|